- Home
- ATRA vs PDSB Comparison
ATRA vs PDSB Comparison
Compare ATRA & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- PDSB
- Stock Information
- Founded
- ATRA 2012
- PDSB 2005
- Country
- ATRA United States
- PDSB United States
- Employees
- ATRA N/A
- PDSB N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ATRA Health Care
- PDSB Health Care
- Exchange
- ATRA Nasdaq
- PDSB Nasdaq
- Market Cap
- ATRA 65.1M
- PDSB 58.7M
- IPO Year
- ATRA 2014
- PDSB N/A
- Fundamental
- Price
- ATRA $9.44
- PDSB $1.59
- Analyst Decision
- ATRA Buy
- PDSB Strong Buy
- Analyst Count
- ATRA 6
- PDSB 3
- Target Price
- ATRA $25.70
- PDSB $14.00
- AVG Volume (30 Days)
- ATRA 436.6K
- PDSB 226.9K
- Earning Date
- ATRA 03-27-2025
- PDSB 03-26-2025
- Dividend Yield
- ATRA N/A
- PDSB N/A
- EPS Growth
- ATRA N/A
- PDSB N/A
- EPS
- ATRA N/A
- PDSB N/A
- Revenue
- ATRA $100,439,000.00
- PDSB N/A
- Revenue This Year
- ATRA $1,339.87
- PDSB N/A
- Revenue Next Year
- ATRA N/A
- PDSB N/A
- P/E Ratio
- ATRA N/A
- PDSB N/A
- Revenue Growth
- ATRA 2111.34
- PDSB N/A
- 52 Week Low
- ATRA $5.40
- PDSB $1.30
- 52 Week High
- ATRA $28.75
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- ATRA 44.94
- PDSB 47.20
- Support Level
- ATRA $8.02
- PDSB $1.52
- Resistance Level
- ATRA $9.10
- PDSB $1.73
- Average True Range (ATR)
- ATRA 1.12
- PDSB 0.14
- MACD
- ATRA -0.02
- PDSB 0.04
- Stochastic Oscillator
- ATRA 45.13
- PDSB 63.16
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.